Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia

HyeJin Shi,1 Jin Seo Lee,2 So Yeon Park,2 Yousang Ko,2 Joong Sik Eom1 1Division of Infectious Diseases, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea; 2Division of Infectious Diseases, Kangdong Sacred Heart Hospital, Hallym University School of Medicine, Seoul...

Full description

Bibliographic Details
Main Authors:	Shi H, Lee JS, Park SY, Ko Y, Eom JS
Format:	Article
Language:	English
Published:	Dove Medical Press 2019-12-01
Series:	Infection and Drug Resistance
Subjects:	carbapenem-resistant acinetobacter baumannii (crab) pneumonia colistin combination therapy risk factor
Online Access:	https://www.dovepress.com/colistin-plus-carbapenem-versus-colistin-monotherapy-in-the-treatment--peer-reviewed-article-IDR

Similar Items

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study
by: Rujipas Sirijatuphat, et al.
Published: (2022-11-01)

Effectiveness of Colistin in carbapenem resistant Acinetobacter baumannii – A systematic review
by: Feroz Ahmed, et al.
Published: (2023-09-01)

Ineffectiveness of colistin monotherapy in treating carbapenem-resistant Acinetobacter baumannii Pneumonia: A retrospective single-center cohort study
by: Cheon-Hoo Jeon, et al.
Published: (2024-05-01)

Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe
by: Ivana Goic-Barisic, et al.
Published: (2023-06-01)

Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin and sitafloxacin, alone and in combination, against carbapenem-, multidrug-, and colistin-resistant Acinetobacter baumannii
by: Vipavee Rodjun, et al.
Published: (2023-11-01)

Efficacy of colistin and rifampin combination for treatment of ventilator associated pneumonia caused by carbapenem resistant Acinetobacter baumannii: brief report
by: Masoomeh Sofian, et al.
Published: (2020-02-01)

Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii
by: Hadas Kon, et al.
Published: (2023-06-01)

A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2020-09-01)

The effectiveness of colistin/levofloxacin compared to colistin/meropenem in the treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii: a randomized controlled clinical trial
by: Mahnaz Momenzadeh, et al.
Published: (2023-01-01)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021-08-01)

Pharmacodynamics of colistin against Acinetobacter baumannii
by: Mohd Rasidin, Rashizal Sazli
Published: (2017)

Colistin Dependency among Colistin-Heteroresistant <i>Acinetobacter baumannii</i> Isolates
by: Hadas Kon, et al.
Published: (2021-12-01)

Synergistic Activity of Capsaicin and Colistin Against Colistin-Resistant Acinetobacter baumannii: In Vitro/Vivo Efficacy and Mode of Action
by: Tingting Guo, et al.
Published: (2021-09-01)

Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates
by: Saranya Vijayakumar, et al.
Published: (2024-02-01)

Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant <i>Acinetobacter baumannii</i>: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2021-01-01)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01)

Colistin and carbapenem resistance among Pseudomonas and Acinetobacter clinical isolates in Menoufia University Hospitals
by: Amal Makled, et al.
Published: (2024-02-01)

In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant Acinetobacter Baumannii
by: Alessandra Oliva, et al.
Published: (2019-03-01)

Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant <i>Acinetobacter baumannii</i> Infection: A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2022-06-01)

Intrapulmonary and Systemic Pharmacokinetics of Colistin Following Nebulization of Low-Dose Colistimethate Sodium in Patients with Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Dong-Hwan Lee, et al.
Published: (2024-03-01)

Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study
by: Davide Fiore Bavaro, et al.
Published: (2023-09-01)

Colistin for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
by: Jun-Yuan Zheng, et al.
Published: (2020-12-01)

Risk Factors Associated With Colistin-Resistant Acinetobacter baumannii Infection
by: Hae-Sun Chung, et al.
Published: (2023-06-01)

Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii
by: Bin Liu, et al.
Published: (2014-07-01)

Potentiation of antimicrobial activity of colistin with antibiotics of different groups against multidrug- and extensively drug-resistant strains of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa
by: Tapalskiy D.V., et al.
Published: (2020-05-01)

Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment
by: Jeongwoo Jo, et al.
Published: (2023-06-01)

In-silico study of Lebanese herbal compounds against carbapenem-resistant Acinetobacter baumannii proteins
by: Israa Assaf, et al.
Published: (2023-01-01)

Molecular characterization of β-lactamase genes in clinical isolates of carbapenem-resistant Acinetobacter baumannii
by: Kevin M. Raible, et al.
Published: (2017-11-01)

Two types of colistin heteroresistance in Acinetobacter baumannii isolates
by: Yoon-Kyoung Hong, et al.
Published: (2020-01-01)

Investigation of the Synergic Effect of the Colistin/ Sulbactam Combination in Carbapenem-Resistant Acinetobacter baumannii complex Strains with Time-Kill and Checkerboard Methods
by: İmdat KILBAŞ, et al.
Published: (2021-03-01)

Clinical Outcomes Of Colistin In Combination With Either 6-G Sulbactam Or Carbapenems For The Treatment Of Extensively Drug-Resistant Acinetobacter Baumannii Pneumonia With High MIC To Sulbactam, A Prospective Cohort Study
by: Ungthammakhun C, et al.
Published: (2019-09-01)

Investigation of Colistin Heteroresistance and Some Factors Affecting Heteroresistance in Carbapenem-Resistant A. baumannii Strains
by: Deniz GAZEL, et al.
Published: (2017-12-01)

In vitro and in vivo synergistic effect of chrysin in combination with colistin against Acinetobacter baumannii
by: Yining Zhao, et al.
Published: (2022-10-01)

Formation <i>in vitro</i> of colistin resistance in carbapenem-resistant Gram-negative bacteria and its biological cost
by: D. V. Tapalski, et al.
Published: (2021-09-01)

Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
by: Wasan Katip, et al.
Published: (2022-06-01)

Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii
by: Marta Carretero-Ledesma, et al.
Published: (2018-12-01)

Emergence of colistin-heteroresistant and carbapenem-resistant hypervirulent Klebsiella pneumoniae
by: Tao Wang, et al.
Published: (2023-12-01)

Comparative Respiratory Tract Microbiome Between Carbapenem-Resistant Acinetobacter baumannii Colonization and Ventilator Associated Pneumonia
by: Tingting Xiao, et al.
Published: (2022-03-01)

Unusual community-associated carbapenem-resistant Acinetobacter baumannii infection, Pennsylvania, USA
by: Mohamed H. Yassin, et al.
Published: (2020-01-01)